NCT07342218 Correctional Service of Canada Pilot Trial of Digital Substance Use Disorder Interventions (PROCESS)
| NCT ID | NCT07342218 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Joseph's Healthcare Hamilton |
| Condition | Substance Use Disorder (SUD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-02-25 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-02-25 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Problems with substance use are common in prisoners. Since most substances are still illegal in Canada, substance use problems can increase the risk for re-incarceration. Although research suggests that treatment may reduce these risks, they are still rarely used in correctional settings. This pilot study will examine the feasibility and usefulness of two digital treatments for substance use problems in individuals recently released from prison. The investigators will compare engagement across both treatments over a 6-month period, and assess the rates of substance use relapse and re-incarceration.
Eligibility Criteria
Inclusion Criteria: * Individuals who have previously served custodial services in the Correctional Services of Canada (csc). * Individuals who have a history of substance use problems (i.e., determined by them not being allowed to use substances as part their parole terms) * Individuals who current reside in a Community Correctional Centre or Community-Based Residential Facility * Individuals between 18-55 years old Exclusion Criteria: \- Individuals who have never served a custodial sentence with the CSC
Contact & Investigator
James MacKillop, PhD, CPsych, FCAHS
PRINCIPAL INVESTIGATOR
Peter Boris Centre for Addictions Research, St Joseph's Healthcare Hamilton
Frequently Asked Questions
Who can join the NCT07342218 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Substance Use Disorder (SUD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07342218 currently recruiting?
Yes, NCT07342218 is actively recruiting participants. Contact the research team at jmackill@mcmaster.ca for enrollment information.
Where is the NCT07342218 trial being conducted?
This trial is being conducted at Brantford, Canada, Dundas, Canada, Hamilton, Canada, Hamilton, Canada.
Who is sponsoring the NCT07342218 clinical trial?
NCT07342218 is sponsored by St. Joseph's Healthcare Hamilton. The principal investigator is James MacKillop, PhD, CPsych, FCAHS at Peter Boris Centre for Addictions Research, St Joseph's Healthcare Hamilton. The trial plans to enroll 20 participants.